In September 20, 2014, the 17th national congress and 2014 academic conference of clinical oncology had a perfect ending) This year had adhered to the "improve the standard level, expand the international perspective" theme, attracted nearly 20,000 participants from both at home and abroad .Medical examination center of Shanghai Biotecan as exhibitors, respectively for space-unit, topics satellite and transformation of sex research BBS and to carry on the omni-directional, multi-angle display academic achievements and corporate brand image.
Time flies, Biotecan since its establishment in August 2008, after 6 years of exploration and practice, in order to create a "Joint Innovation Center for molecular medicine" as the foundation, big data and clinical data of multi omics and disease composition (big data) were analyzed and the depth of integration of multidimensional mining, personalized medicine the standard is developed for various diseases and clinical application of product development mode，At present Shanghai Biotecan has in the establishment of more than twenty joint Center for molecular medicine, formed the headquarters in Shanghai, a large network of medical radiation data of provinces and cities nationwide.At present Shanghai Biotecan has in the establishment of more than twenty joint Center for molecular medicine, formed the headquarters in Shanghai, a large network of medical radiation data of provinces and cities nationwide.At present Shanghai Biotecan has in the establishment of more than twenty joint Center for molecular medicine, formed the headquarters in Shanghai, a large network of medical radiation data of provinces and cities nationwide.
Fudan - ZhangJiang clinical genomics research center held "The Fifth big data information seminar at School of Medicine，Fudan University in August 18, 2014. The esophageal cancer project of Henan province was reported and discussed of initial results in this seminar.
Shanghai zhangjiang translational medicine R&D center is committed to collaborative gathers numerous advantage resources, plans to build a national medical industrialization of achievement of big data and biological pharmaceutical innovation system，Otherwise，the R&D center undertake major national research projects, including the establishment of the individualized medical standards, demonstration, application and promotion, and other important tasks.cine R&D center of second military medical university-zhangjiang, and building the establishment of individualized medicine big data cloud computing platform.
From June 19, 2014 to June 22nd, the 8th APEC (Asia Pacific Economic Cooperation) small and medium enterprises technology conference and fair (hereinafter referred to as the
From May 30, 2014 to June 1st, medical examination center of Shanghai Biotecan and Shanghai Zhangjiang translational medicine research center held a successful project communication meeting of building joint molecular medicine center in Shanghai Zhangjiang Berkeley Engineering Innovation Center. More than 10 provinces, cities' enterprises who came from Shanxi, Henan, Hubei, Hunan, Jiangsu, Sichuan and other countries attended this meeting. In addition, the Biotecan regional center for molecular medicine and sales team representatives attended this meeting, too.
First Shanghai Centre, 180 Zhangheng Rd., Pudong New District, Shanghai, China